MARY GAMLIN: Open Payments
NPI 1457805541 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,655 in 75 payments from 16 companies in 2025. Trend: 2023 $883 · 2024 $1,858 · 2025 $1,655
Food & beverage: $1,655
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $259 |
| ABBVIE INC. | 12 | $220 |
| Neurocrine BioSciences, Inc. | 8 | $214 |
| Otsuka America Pharmaceutical, Inc. | 4 | $187 |
| Lundbeck LLC | 7 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $98 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 4 | $77 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| HARMONY BIOSCIENCES LLC | 3 | $64 |
Products named: VRAYLAR, REXULTI, INGREZZA, FANAPT, ABILIFY ASIMTUFII, CAPLYTA, HETLIOZ, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
